Cefaly: Difference between revisions
Removing redundant links |
Fix references and other minor tweaks |
||
Line 3: | Line 3: | ||
<!--- Important, do not remove this line before article has been created. ---> |
<!--- Important, do not remove this line before article has been created. ---> |
||
Cefaly is an external cranial [[neurostimulator]] indicated for the treatment and prevention of migraine and tension |
Cefaly is an external cranial [[neurostimulator]] indicated for the treatment and prevention of [[migraine]] and [[tension headaches]]. Cefaly is intended for patients who suffer from frequent severe migraines or headaches, especially when drugs consumption is to be reduced. The Cefaly technology can also be used in order to produce a sedative effect.<ref name="piquet2011">{{cite journal|author1= Piquet M|author2= Balestra C|author3= Sava SL|author6= Schoenen J|title=Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects|journal= BMC Neurol|date= 2011 Oct 28|volume=11|page=135.|doi=10.1186/1471-2377-11-135. |PMID= 22035386}}</ref> |
||
== Biomedical principles == |
== Biomedical principles == |
||
Line 9: | Line 9: | ||
== Neurostimulation == |
== Neurostimulation == |
||
Cranial neurostimulation has generally been used with implantable devices similar to [[Artificial cardiac pacemaker|pacemakers]]. Cefaly’s great advantage is to allow this neurostimulation technique to be used in an external way that does not require any surgery as opposed to implanted devices. This external cranial neurostimulation technology is made possible thanks to the high specificity and precision of the electrical micro-impulses able to trigger the excitation of the focused nerve fibres ([[axon]]s) without causing strong pain in cranial [[periosteum]]. Many recent studies have demonstrated the high safety and the efficacy of the Cefaly for the migraine treatment and prevention<ref name="schoenen2013"> Schoenen J |
Cranial neurostimulation has generally been used with implantable devices similar to [[Artificial cardiac pacemaker|pacemakers]]. Cefaly’s great advantage is to allow this neurostimulation technique to be used in an external way that does not require any surgery as opposed to implanted devices. This external cranial neurostimulation technology is made possible thanks to the high specificity and precision of the electrical micro-impulses able to trigger the excitation of the focused nerve fibres ([[axon]]s) without causing strong pain in cranial [[periosteum]]. Many recent studies have demonstrated the high safety and the efficacy of the Cefaly for the migraine treatment and prevention<ref name="schoenen2013">{{cite journal|author1= Schoenen J|author2= Vandersmissen B|author3= Jeangette S|author4= Herroelen L|author6= Vandenheede M|author7= Gérard P|author8= Magis D| title=Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial| journal=Neurology|year=2013|volume=80|pages=697-704| PMID=23390177}}</ref><ref name="magis2013">{{cite journal|author1= Magis D|author2= Sava S|author3= D Elia TS|author4= Baschi R|author5= Schoenen J| title=Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population.|journal= J Headache Pain| date= 2013 Dec 1|volume=14(1)|page=95| PMID= 24289825}}</ref> |
||
== References == |
== References == |
||
Line 19: | Line 19: | ||
{{Portal|Technology|Medicine}} |
{{Portal|Technology|Medicine}} |
||
[[:Category: Medical treatments]] |
[[:Category: Medical treatments]] [[:Category: Headaches]] |
||
== References == |
|||
{{reflist}} |
|||
<!--- After listing your sources please cite them using inline citations and place them after the information they cite. Please see [[Wikipedia:REFB]] for instructions on how to add citations. ---> |
|||
* Piquet M, Balestra C, Sava SL, Schoenen J, « Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects » BMC Neurol 2011 Oct 28;11:135. doi: 10.1186/1471-2377-11-135. |
|||
* Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gérard P, and Magis D, « Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial »Neurology 2013;80:697-704. |
|||
* Magis D, Sava S, D Elia TS, Baschi R, Schoenen J. « Safety and patients’ satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population."J Headache Pain 2013 Dec 1;14(1):95. |
Revision as of 23:45, 21 January 2014
This article, Cefaly, has recently been created via the Articles for creation process. Please check to see if the reviewer has accidentally left this template after accepting the draft and take appropriate action as necessary.
Reviewer tools: Inform author |
Cefaly is an external cranial neurostimulator indicated for the treatment and prevention of migraine and tension headaches. Cefaly is intended for patients who suffer from frequent severe migraines or headaches, especially when drugs consumption is to be reduced. The Cefaly technology can also be used in order to produce a sedative effect.[1]
Biomedical principles
Cefaly is an electronic medical device that produces electrical micro-impulses. These pulses are intented to trigger excitations, i.e. action potentials on the nerve fibres of either the superior branch of the trigeminal nerve via a electrode placed on the forehead, or of the major occipital nerve (Arnold’s nerve) via a occipital electrode.
Neurostimulation
Cranial neurostimulation has generally been used with implantable devices similar to pacemakers. Cefaly’s great advantage is to allow this neurostimulation technique to be used in an external way that does not require any surgery as opposed to implanted devices. This external cranial neurostimulation technology is made possible thanks to the high specificity and precision of the electrical micro-impulses able to trigger the excitation of the focused nerve fibres (axons) without causing strong pain in cranial periosteum. Many recent studies have demonstrated the high safety and the efficacy of the Cefaly for the migraine treatment and prevention[2][3]
References
- ^ Piquet M; Balestra C; Sava SL (2011 Oct 28). "Supraorbital transcutaneous neurostimulation has sedative effects in healthy subjects". BMC Neurol. 11: 135. doi:10.1186/1471-2377-11-135.. PMID 22035386.
{{cite journal}}
: Check|doi=
value (help); Check date values in:|date=
(help) - ^ Schoenen J; Vandersmissen B; Jeangette S; Herroelen L; Vandenheede M; Gérard P; Magis D (2013). "Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trial". Neurology. 80: 697–704. PMID 23390177.
{{cite journal}}
: Missing|author5=
(help) - ^ Magis D; Sava S; D Elia TS; Baschi R; Schoenen J (2013 Dec 1). "Safety and patients' satisfaction of transcutaneous Supraorbital NeuroStimulation (tSNS) with the Cefaly® device in headache treatment: a survey of 2,313 headache sufferers in the general population". J Headache Pain. 14(1): 95. PMID 24289825.
{{cite journal}}
: Check date values in:|date=
(help)